Magnetismm-3: An open-label, multicenter, non-randomized phase 2 study of elranatamab (PF-06863135) in patients with relapsed or refractory multiple myeloma Meeting Abstract
| Authors: | Lesokhin, A.; Iida, S.; Stevens, D.; Gabayan, A. E.; Ma, W. D.; Sullivan, S.; Raab, M. S. |
| Abstract Title: | Magnetismm-3: An open-label, multicenter, non-randomized phase 2 study of elranatamab (PF-06863135) in patients with relapsed or refractory multiple myeloma |
| Meeting Title: | 63rd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 138 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Dec 11-14 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2021-11-23 |
| Language: | English |
| ACCESSION: | WOS:000736398806142 |
| DOI: | 10.1182/blood-2021-152984 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1674 -- Hybrid meeting, also took place online -- Source: Wos |
